Dyserythropoiesis associated with a Fas-deficient condition in childhood

British Journal of Haematology

Volumn 108, Issue 2, 2000, Pages 300-304

  Bader Meunier, Brigitte ^a   Rieux Laucat, Frederic ^b   Croisille, Laure ^a   Yvart, Jeanine ^a   Mielot, Francoise ^a   Dommergues, Jean Paul ^a   Ledeist, Francoise ^b   Tchernia, Gil ^a  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Apoptosis; Autoimmunity; Dyserythropoiesis; Fas mutation; Haemolytic anaemia

Indexed keywords

FAS ANTIGEN; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CHILD; DYSERYTHROPOIESIS; GENE MUTATION; HEMOLYTIC ANEMIA; HUMAN; HYPERGAMMAGLOBULINEMIA; INFANT; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL;

ANEMIA, HEMOLYTIC; ANTIGENS, CD95; APOPTOSIS; CHILD; ERYTHROPOIESIS; HUMANS; INFANT; MALE; MUTATION;

EID: 0034099058     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01862.x     Document Type: Article

References (19)

1. Adachi, M., Watanabe-Fukunaga, R. & Nagata, S. (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proceedings of the National Academy of Sciences of the United States of America, 90, 1756-1760.
2. Alderson, M.R., Tough, T.W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K.A., Goodwin, R.G., Smith, C.A., Ramsdell, F. & Lynch, D.H. (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. Journal of Experimental Medicine, 181, 71-77.
3. De Maria, R., Testa, U., Luchetti, L., Zeuner, A., Stassi, G., Pelosi, E., Riccioni, R., Felli, N., Samoggia, P. & Peschle, C. (1999) Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood, 93, 796-803.
4. Dianzani, U., Bragardo, M., DiFranco, D., Alliaudi, C., Scagni, P., Buonfiglio, D., Redoglia, V., Bonissoni, S., Correra, A., Dianzani, I. & Ramenghi, U. (1997) Deficiency of the Fas apoptotic pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood, 89, 2871-2878.
5. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J. & Puck, J.M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell, 81, 935-946.
6. Izui, S., Kelley, V.E., Masuda, K., Yoshida, H., Roths, J.B. & Murphy, E.D. (1984) Induction of various autoantibodies by mutant gene lpr in several strains of mice. Journal of Immunology, 133, 227-233.
7. Jimenez-Balderas, F.J., Morales-Polanco, M.R. & Guttierez, L. (1994) Acute sideroblastic anemia in active systemic lupus erythematosus. Lupus, 3, 157-159.
8. Kettaneh, A., Hayem, G., Palazzo, E., Debandt, M., Lebail-Darné, J.L., Roux, S., Kahn, M.F. & Meyer, O. (1998) Une observation de rémission post partum d'une dyserythropoièse acquise, une cause rare d'anémie au cours du lupus érythémateux disséminé. Revue de Médecine Interne, 19, 571-574.
9. Le Deist, F., Emile, J.F., Rieux-Laucat, F., Benkerrou, M., Roberts, I., Brousse, N. & Fisher, A. (1996) Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet, 348, 719-723.
10. Liu, H., Ozaki, K., Matsuzaki, Y., Abe, M., Kosaka, M. & Saito, S. (1995) Suppression of hematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE). Clinical Experimental Immunology, 100, 480-485.
11. Miescher, P., Favre, H. & Beris, P. (1991) Autoimmune myelodysplasias. Seminars in Hematology, 28, 322-330.
12. Nagata, S. & Goldstein, P. (1995) The Fas death factor. Science, 267, 1449-1456.
13. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A.G., Debatin, K.M., Fisher, A. & de Villartray, J.P. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 268, 1347-1349.
14. Rieux-Laucat, F., Blachère, S., Daniélan, S., de Villartray, J.P., Oleastro, M., Solary, E., Bader-Meunier, B., Arkwright, P., Pondaré, C., Bernaudin, F., Chapel, H., Nielsen, S., Berrah, M., Fisher, A. & Le Deist, F. (1999) Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood, 94, 2575-2582.
15. Roth, J. (1987) New Horizons in Animal Models for Autoimmune Disease (ed. by H. Wigzell and M. Kyogoku), pp. 21-33. Academic Press, Tokyo.
16. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Singer, G. & Ab Bas, A.K. (1994) The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity, 1, 365-371.
18. Sneller, M.C., Wang, J., Dale, J.K., Strober, W., Middelton, L.A., Choi, Y., Fleisher, T.A., Lim, M.S., Jaffe, E.S., Puck, J.M., Lenardo, M.J. & Strauss, S.E. (1997) Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood, 89, 1341-1348.
19. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T. & Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76, 969-976.